Viking Therapeutics (NASDAQ:VKTX), Others Gain After Novo Nordisk (NYSE:NVO) Data Falls Short of ExpectationsEli Lilly & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results